Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

EPA/AELIS stock hub

EPA/AELIS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

EPA/AELISis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

17.1M

Euronext Paris

Market data

Price

Recent price action with selectable time range.

EPA/AELISEPA/AELIS

—

Loading chart…

In the news

Latest news · EPA/AELIS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-102.1

P25 n/aP50 n/aP75 n/a

ROIC-371.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All EPA/AELIS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

EUR

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	FR
Employees	24
Employees Change	-4%
Employees Change Percent	-14.29
Enterprise value	EUR 13.2M
Exchange	Euronext Paris
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FR0014007ZB4
Last refreshed	2026-05-10
Market cap	EUR 17.1M
Price	EUR 1.26
Price currency	EUR
Rev Per Employee	97,208.33x
Sector	Healthcare
Sic	2836
Symbol	epa/AELIS
Website	https://www.aelisfarma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-47.93%
EV Earnings	-1.61x
EV/FCF	-1.74x
EV/Sales	5.66x
FCF yield	-44.26%
P/B ratio	2.8x
P/S ratio	7.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	EUR 2.3M
Gross Profit Growth	-58.05%
Gross Profit Growth Q	-78.3%
Gross Profit Growth3 Y	-42.63%
Gross Profit Growth5 Y	-22.54%
Net Income	EUR -8.2M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-350.79%
Profit Per Employee	EUR -341,500
ROA	-28.5
Roa5y	-13.02
ROCE	-73.75
ROE	-102.1
Roe5y	-7.7
ROIC	-371.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	3.54%
Cagr3y	-55.25%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	-78.36x
Revenue Growth Q	-78.3x
Revenue Growth Years	0x
Revenue Growth3 Y	-42.63x
Revenue Growth5 Y	-22.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.13
Assets	EUR 15.6M
Cash	EUR 10.8M
Current Assets	EUR 14.1M
Current Liabilities	EUR 4.4M
Debt	EUR 6.9M
Debt Equity	EUR 1.13
Debt FCF	EUR -0.91
Equity	EUR 6.1M
Interest Coverage	-32.62
Liabilities	EUR 9.5M
Long Term Assets	EUR 1.5M
Long Term Liabilities	EUR 5M
Net Cash	EUR 3.9M
Net Cash By Market Cap	EUR 22.81
Net Cash Growth	-47.99%
Net Debt Equity	EUR -0.64
Tangible Book Value	EUR 5.9M
Tangible Book Value Per Share	EUR 0.43
WACC	6.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.18
Net Working Capital	EUR 943,000
Quick ratio	3.11
Working Capital	EUR 9.7M
Working Capital Turnover	EUR 0.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	3.54%
200-day SMA	1.25
3Y total return	-91.05%
50-day SMA	1.3
50-day SMA vs 200-day SMA	50over200
All Time High	14.48
All Time High Change	-91.31%
All Time High Date	2022-02-18
All Time Low	0.67
All Time Low Change	87.2%
All Time Low Date	2025-07-23
ATR	0.08
Beta	0.6
Beta1y	-0.14
Beta2y	0.9
Ch YTD	11.82
High	1.28
High52	2.3
High52 Date	2026-01-28
High52ch	-45.3%
Low	1.2
Low52	0.67
Low52 Date	2025-07-23
Low52ch	87.2%
Ma50ch	-2.93%
Price vs 200-day SMA	1.04%
RSI	47.62
RSI Monthly	24.03
RSI Weekly	48.34
Sharpe ratio	0.5x
Sortino ratio	1.14
Total Return	-3.44%
Tr YTD	11.82
Tr1m	-6.26%
Tr1w	-0.94%
Tr3m	-11.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -8.2M
Operating margin	-352.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,881,948%
Net Borrowing	1,752,000
Shares Insiders	38.34%
Shares Institutions	2.94%
Shares Out	13,592,801
Shares Qo Q	0.02%
Shares Yo Y	3.44%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -8M
Average Volume	23,419x
Bv Per Share	0.45
CAPEX	EUR -31,000
Ch1m	-6.26
Ch1w	-0.94
Ch1y	3.54
Ch3m	-11.1
Ch3y	-91.05
Ch6m	13.33
Change	4.83%
Change From Open	-0.79
Close	1.2
Days Gap	5.67
Depreciation Amortization	88,000
Dollar Volume	36,271.9
Earnings Date	2026-09-15
EBIT	EUR -8.2M
EBITDA	EUR -8.1M
EPS	EUR -0.6
F Score	1
FCF	EUR -7.6M
FCF EV Yield	-57.34x
FCF Per Share	EUR -0.56
Financing CF	5,860,000
Fiscal Year End	December
Founded	2,013
Income Tax	EUR 12,000
Investing CF	-31,000
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2025-06-30
Ma150	1.24
Ma150ch	1.21%
Ma20	1.28
Ma20ch	-1.49%
Net CF	-1,803,000
Next Earnings Date	2026-09-15
Open	1.27
Position In Range	72.5
Ppne	1,203,000
Price Date	2026-05-08
Ptbv Ratio	2.89
Relative Volume	1.25x
Revenue	2,333,000x
SBC By Revenue	18.86x
Share Based Comp	440,000
Tax By Revenue	0.51x
Tr6m	13.33%
Volume	28,833
Z Score	2.28

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does EPA/AELIS pay a dividend?

Capital-return profile for this ticker.

Performance

EPA/AELIS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns EPA/AELIS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.9%

Share of float held by funds and institutions

Insider ownership

+38.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+3.4%

Negative means the company is buying back shares.

Technical

EPA/AELIS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.6

Neutral momentum band

Price vs 200-day MA

+1.0%

50/200-day relationship not available

Beta (5Y)

0.60

Less volatile than the market

Sharpe ratio

0.50

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About EPA/AELIS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current epa/AELIS stock rating?

epa/AELIS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full epa/AELIS analysis?

The full report lives at /stocks/epa/AELIS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for epa/AELIS?

The latest report frames epa/AELIS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the epa/AELIS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.